Crosstalk between TRPV1 and immune regulation in Fuchs endothelial corneal dystrophy.
Fuchs endothelial corneal dystrophy
Gene therapy
Immune landscape
Regulatory T cell
Transient receptor potential vanilloid 1
Journal
Clinical immunology (Orlando, Fla.)
ISSN: 1521-7035
Titre abrégé: Clin Immunol
Pays: United States
ID NLM: 100883537
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
received:
17
04
2023
revised:
25
06
2023
accepted:
18
07
2023
medline:
14
8
2023
pubmed:
24
7
2023
entrez:
23
7
2023
Statut:
ppublish
Résumé
Fuchs endothelial corneal dystrophy (FECD) is the leading indication for corneal transplantation worldwide. Our aim was to investigate the role of transient receptor potential vanilloid subtype 1 (TRPV1) and the associated immune regulation contributing to this pathological condition. Significant upregulation of TRPV1 was detected in the H
Identifiants
pubmed: 37482117
pii: S1521-6616(23)00464-3
doi: 10.1016/j.clim.2023.109701
pii:
doi:
Substances chimiques
Hydrogen Peroxide
BBX060AN9V
TRPV1 protein, human
0
TRPV Cation Channels
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
109701Informations de copyright
Copyright © 2023. Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Declaration of Competing Interest No competing interests is declared.